Javascript must be enabled to continue!
CORRELATION OF CARDIAC TROPONIN I WITH VENTRICULAR ARRHYTHMIA AND LATE PROGNOSIS IN THE PATIENTS WITH CHRONIC HEART FAILURE
View through CrossRef
Objectives
TO investigate correlation of cardiac troponin I (cTnI) with ventricular arrhythmia and late prognosis in the patients with chronic heart failure (CHF).
Methods
The levels of serum cardiac troponin I (cTnI) of 174 patients with chronic heart failure (CHF) were detected. The patients were divided into two groups: cTnI -postive group with serum cTnI ≥0.16 ng/ml (n=78) and cTnI–negative group with serum cTnI<0.16 ng/ml (n=96). Ventricular arrhythmia was assessed by 24 h Holter monitoring in two groups. The incidence of adverse cardiac events, re-hospitalisation mortality during the period of in-hospital and the 6 months of out-of-hospital were observed and followed up.
Results
Mean hourly number of single ventricular premature beats, Mean hourly ventricular pairs, and the frequency of ventricular tachycardia episodes per 24 h in cTnI-positive group were significantly higher than those in cTnI-negative group (all p<0.01); during the period of observation and follow-up, the incidence of adverse cardiac events, re-hospitalisation and mortality of patients in cTnI-positive group were significantly higher than those in cTnI-negative group (all p<0.05).
Conclusions
Serum cTnI levels correlated with ventricular arrhythmia and late prognosis, which could be used as a prognosis predicting for patients with CHF.
Title: CORRELATION OF CARDIAC TROPONIN I WITH VENTRICULAR ARRHYTHMIA AND LATE PROGNOSIS IN THE PATIENTS WITH CHRONIC HEART FAILURE
Description:
Objectives
TO investigate correlation of cardiac troponin I (cTnI) with ventricular arrhythmia and late prognosis in the patients with chronic heart failure (CHF).
Methods
The levels of serum cardiac troponin I (cTnI) of 174 patients with chronic heart failure (CHF) were detected.
The patients were divided into two groups: cTnI -postive group with serum cTnI ≥0.
16 ng/ml (n=78) and cTnI–negative group with serum cTnI<0.
16 ng/ml (n=96).
Ventricular arrhythmia was assessed by 24 h Holter monitoring in two groups.
The incidence of adverse cardiac events, re-hospitalisation mortality during the period of in-hospital and the 6 months of out-of-hospital were observed and followed up.
Results
Mean hourly number of single ventricular premature beats, Mean hourly ventricular pairs, and the frequency of ventricular tachycardia episodes per 24 h in cTnI-positive group were significantly higher than those in cTnI-negative group (all p<0.
01); during the period of observation and follow-up, the incidence of adverse cardiac events, re-hospitalisation and mortality of patients in cTnI-positive group were significantly higher than those in cTnI-negative group (all p<0.
05).
Conclusions
Serum cTnI levels correlated with ventricular arrhythmia and late prognosis, which could be used as a prognosis predicting for patients with CHF.
Related Results
Additional PKA phosphorylation sites in human cardiac troponin I
Additional PKA phosphorylation sites in human cardiac troponin I
We used mass spectrometry to monitor cAMP‐dependent protein kinase catalysed phosphorylation of human cardiac troponin I in vitro. Phosphorylation of isolated troponin I by cAMP‐de...
Phosphorylation of troponin and the effects of interactions between the components of the complex
Phosphorylation of troponin and the effects of interactions between the components of the complex
1. The troponin complex from skeletal muscle contains approximately 1 mol of phosphate/80000g of complex, covalently bound to the troponin T component. 2. On prolonged incubation o...
The phosphorylation of troponin I from cardiac muscle
The phosphorylation of troponin I from cardiac muscle
1. Troponin I isolated from fresh cardiac muscle by affinity chromatography contains about 1.9 mol of covalently bound phosphate/mol. Similar preparations of white-skeletal-muscle ...
Misleading Elevation of Troponin T caused by Polymyositis
Misleading Elevation of Troponin T caused by Polymyositis
Background: Elevations of cardiac enzymes are commonly used to indicate myocardial ischemia, but they can be elevated due to other conditions. Different forms of Troponin (cTnT, sT...
Structural dynamics of the intrinsically disordered linker region of cardiac troponin T
Structural dynamics of the intrinsically disordered linker region of cardiac troponin T
ABSTRACTThe cardiac troponin complex, composed of troponins I, T, and C, plays a central role in regulating the calcium-dependent interactions between myosin and the thin filament....
Stabilisation of medically refractory ventricular arrhythmia by intra-aortic balloon counterpulsation
Stabilisation of medically refractory ventricular arrhythmia by intra-aortic balloon counterpulsation
OBJECTIVE
To review the efficacy of intra-aortic balloon counterpulsation (IABCP) in medically refractory ventricular arrhythmia.
...
Effect of WenXin KeLi on Improvement of Arrhythmia after Myocardial Infarction by Intervening PI3K-AKT-mTOR Autophagy Pathway
Effect of WenXin KeLi on Improvement of Arrhythmia after Myocardial Infarction by Intervening PI3K-AKT-mTOR Autophagy Pathway
Background. Myocardial infarction (MI) is an acute and serious cardiovascular disease. Arrhythmia after MI can lead to sudden cardiac death, which seriously affects the survival ou...
Cardiac manifestations of fabry disease in female patients: a single centre experience
Cardiac manifestations of fabry disease in female patients: a single centre experience
Abstract
Introduction
Fabry disease is a lysosomal storage disorder resulting in multisystemic effects due to deposition and acc...

